Zimhi Injection, Solution
Product Images NDC 84571-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Zimhi (NDC 84571-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zmi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Do Not Attempt To Reuse Zimhi. Each Zimhi Contains A Single-dose Of Naloxone Hydrochloride For Single-dose Injection. (Zimhi 01)

Do Not Attempt To Reuse Zimhi. Each Zimhi Contains A Single-dose Of Naloxone Hydrochloride For Single-dose Injection. (Zimhi 01)
This text describes components of a syringe, including a removable needle cap, plunger, safety guard, and solution window. The syringe barrel is likely designed for medical or laboratory use.*
FDA Label Image

Embed The Needle Completely Before Transferring The Thumb To The Syringe Plunger. (Zimhi 02)

FDA Label Image

Immediately After Injection, Using One Hand With Fingers Behind The Needle, Slide The Safety Guard Over The Needle. Do Not Use Two Hands To Activate The Safety Guard. (Zimhi 03)

FDA Label Image

Structural Formula For Naloxone Hydrochloride (Zimhi 04)

FDA Label Image

Figure 1 Mean ± Sd Plasma Concentration Of Naloxone, (a) 0-30 Min And (b) 0-12 H Following A Single Intramuscular Administration Of 5 mg Zimhi And A Single Intramuscular Administration Of 2 mg Naloxo (Zimhi 05)

FDA Label Image

Mean ± Sd Plasma Concentration Of Naloxone, (a) 0-1 H And (b) 0-12 H Following Intramuscular/subcutaneous Administration Using Zimhitm (Zimhi 06)

FDA Label Image

Zimhitm Works Like A Standard Prefilled Syringe. (Zimhi 07)

FDA Label Image

Zimhitm Is Injected Downwards, Into The Thigh, (as Shown), Through Clothing If Necessary. (Zimhi 08)

FDA Label Image

Ready To Use Zimhitm (Zimhi 09)

FDA Label Image

When Ready To Inject, Pull Off Cap To Expose Needle. (Zimhi 0a)

FDA Label Image

Hold Zimhi By Finger Grips Only And Slowly Insert The Needle Into The Thigh. (Zimhi 0b)

Hold Zimhi By Finger Grips Only And Slowly Insert The Needle Into The Thigh. (Zimhi 0b)
This text appears to be a list of components related to a syringe: - Syringe barrel - Removable needle cap - Plunger - Safety guard - Solution window It seems to describe the parts of a syringe which may be useful for medical or laboratory purposes.*
FDA Label Image

Number 3 (Zimhi 0c)

FDA Label Image

After Needle Is In Thigh: Push The Plunger All The Way Down Until It Clicks And Hold For 2 Seconds. (Zimhi 0d)

FDA Label Image

Number 4 (Zimhi 0e)

FDA Label Image

Right After The Injection, Using One Hand With Fingers Behind The Needle, Slide The Safety Guard Over The Needle. Do Not Use Two Hands To Activate The Safety Guard. Put The Used Syringe Into The Blue (Zimhi 0f)

Right After The Injection, Using One Hand With Fingers Behind The Needle, Slide The Safety Guard Over The Needle. Do Not Use Two Hands To Activate The Safety Guard. Put The Used Syringe Into The Blue (Zimhi 0f)
Safety Guard*
FDA Label Image

Number 5 (Zimhi 10)

FDA Label Image

Get Emergency Medical Help Now (Zimhi 11)

FDA Label Image

Turn The Patient On Their Side (recovery Position) After Giving Zimhi. (Zimhi 12)

FDA Label Image

Use Second Syringe If Necessary (Zimhi 13)

FDA Label Image

Ndc 84571-140-02rx Onlyzimhitm(naloxone HCl Injection, Usp)5 mg/ 0.5 mL (Zimhi 14)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.